查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612802

心臟標記測試市場：按產品、生物標記、測試類型、疾病 - 全球預測 2025-2030

Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心臟標記檢測市場價值為51億美元，預計2024年將達到55億美元，複合年成長率為7.90%，預計到2030年將達到86.9億美元。

心臟標記檢測是透過檢測血液中的特定生物分子來診斷和治療心血管疾病（主要是心臟病發作和急性冠狀動脈症候群）的重要過程。心臟標記檢測的需求源於其在提供有效患者管理和治療所需的快速、準確診斷方面的作用。此測試在緊急情況下尤其重要，例如對於出現胸痛等症狀或可能患有心肌梗塞的患者。心臟標記測試的應用遍及醫院、診所和診斷實驗室，主要最終用戶是需要及時可靠的資料來做出治療決策的醫療保健專業人員。

主要市場統計
基準年[2023] 51億美元
預測年份 [2024] 55億美元
預測年份 [2030] 86.9億美元
複合年成長率（%） 7.90%

心臟標記檢測市場的成長受到心血管疾病盛行率上升、人口老化和診斷技術進步的顯著影響。該領域的顯著商機包括就地檢驗設備的開發和整合，這些設備可以快速提供結果，並且由於其便利性和效率而受到很高的需求。高靈敏度檢測系統的出現為技術創新和提高市場滲透率提供了進一步的機會。儘管存在這些機遇，但先進測試技術的高成本、監管複雜性和報銷問題等挑戰正在限制市場成長。此外，市場面臨來自替代診斷方法的競爭，這可能會阻礙市場擴張。

創新和研發的機會在於開發多標記測試組，提供全面的心臟概況，並結合人工智慧以更好地預測分析心臟事件的診斷。尖端研究還可以集中於識別新型心臟生物標記物，以提高診斷準確性和預後價值。該市場的特點是技術快速進步和競爭格局激烈，需要持續創新和策略聯盟。公司可以透過投資研發、擴大產品系列併採用先進技術來滿足醫療保健提供者不斷變化的需求，從而實現成長並確保市場相關性和競爭力。

市場動態：揭示快速發展的心臟標記測試市場的關鍵市場洞察

供需的動態交互作用正在改變心臟標記檢測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 心血管疾病的流行和有效診斷的必要性
    • 全球心臟標記就地檢驗的興起
    • 努力鼓勵心血管疾病的早期發現和篩檢
  • 市場限制因素
    • 心臟標記檢測產品的不利召回
  • 市場機會
    • 測試技術的進步和新生物標記的整合
    • 介紹向個人化醫療和客製化心臟標記測試的轉變
  • 市場挑戰
    • 對心臟標記測試不準確和特異性有限的擔憂

波特五力：駕馭心臟標記測試市場的策略工具

波特的五力框架是了解心臟標記測試市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心臟標記測試市場的外部影響

外部宏觀環境因素在塑造心臟標記檢測市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解心臟標記檢測市場的競爭狀況

心臟標記物測試市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣心臟標記測試市場供應商的績效評估

FPNV定位矩陣是評估心臟標記檢測市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製心臟標記測試市場的成功之路

心臟標記測試市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心血管疾病的盛行率和有效診斷的必要性
      • 全球就地檢驗有所增加
      • 努力促進心血管疾病的早期發現和篩檢
    • 抑制因素
      • 心臟標記物測試產品的不良召回
    • 機會
      • 測試技術的進步和新生物標記的整合
      • 介紹向個人化醫療和客製化醫療的轉變
    • 任務
      • 對心臟標記測試的不準確性和特異性有限的擔憂
  • 市場區隔分析
    • 產品：診斷設備在心臟標記檢測中的重要性
    • 生物標記：在心臟評估中增加肌鈣蛋白生物標記的使用
    • 測試類型：更多採用就地檢驗
    • 疾病：心臟標記檢測在心肌梗塞的廣泛應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章心臟標記測試市場：依產品

  • 裝置
    • 化學冷光
    • 酵素連結免疫吸附試驗
    • 層析法
    • 螢光
  • 試劑和套件

第7章心臟標記測試市場生物標記物

  • BNP 或 NT-ProBNP
  • 絲氨酸激酶-MB
  • hs-CRP
  • 肌紅蛋白
  • 肌鈣蛋白

第8章按測試類型分類的心臟標記測試市場

  • 臨床檢查
  • 就地檢驗

第9章心臟標記檢測市場：依疾病分類

  • 鬱血性心臟衰竭
  • 心肌梗塞

第10章 北美和南美心臟標記檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太心臟標記檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲心臟標記檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 邁瑞推出新檢測方法，擴大心臟生物標記產品組合
    • NOWDx 和 AeenaDx 宣布合併
    • Pathkind Labs 和羅氏診斷公司合作發布心臟生物標記
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Assure Tech（Hangzhou）Co., Ltd.
  • Atlas Medical GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biomerieux SA
  • Boditech Med Inc.
  • Charles River Laboratories International, Inc.
  • Cleerly, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • HyTest Ltd.
  • Laboratory Corporation of America Holdings
  • LightDeck Diagnostics
  • Merck KGaA
  • Natera, Inc.
  • PerkinElmer Inc.
  • Qiagen NV
  • Quest Diagnostics
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Sekbio
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
Product Code: MRR-034230D3E2E7

The Cardiac Marker Testing Market was valued at USD 5.10 billion in 2023, expected to reach USD 5.50 billion in 2024, and is projected to grow at a CAGR of 7.90%, to USD 8.69 billion by 2030.

Cardiac marker testing is a critical process in diagnosing and managing cardiovascular diseases, primarily heart attacks and acute coronary syndromes, through the detection of specific biomolecules in the blood. The necessity of cardiac marker testing stems from its role in providing rapid, accurate diagnosis necessary for effective patient management and treatment. This testing is crucial in emergency settings, particularly for patients exhibiting symptoms such as chest pain or other potential indications of myocardial infarction. The applications of cardiac marker testing extend to hospitals, clinics, and diagnostic laboratories, with key end-users being healthcare professionals who require timely and reliable data to inform treatment decisions.

KEY MARKET STATISTICS
Base Year [2023] USD 5.10 billion
Estimated Year [2024] USD 5.50 billion
Forecast Year [2030] USD 8.69 billion
CAGR (%) 7.90%

Market growth for cardiac marker testing is significantly influenced by the rising prevalence of cardiovascular diseases, an aging population, and advancements in diagnostic technologies. Notable opportunities in this field include the development and integration of point-of-care testing devices, which offer quick results and are increasingly in demand due to their convenience and efficiency. The advent of high-sensitivity assay systems further presents opportunities for innovation and improved market penetration. Despite these opportunities, challenges such as high cost of advanced testing technologies, regulatory complexities, and reimbursement issues pose limitations to market growth. Additionally, the market faces competition from alternative diagnostic modalities, which might hinder its expansion.

Innovation and research opportunities lie in the development of multi-marker testing panels that provide comprehensive cardiac profiles and the incorporation of artificial intelligence for better predictive analytics in diagnosing cardiac events. Cutting-edge research could also focus on identifying novel cardiac biomarkers that enhance diagnostic accuracy and prognostic value. The nature of the market is characterized by rapid technological advancements and a competitive landscape, necessitating continuous innovation and strategic partnerships. Businesses can achieve growth by investing in R&D, expanding their product portfolios, and adopting technological advancements to meet the evolving needs of healthcare providers, ensuring market relevance and competitiveness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Marker Testing Market

The Cardiac Marker Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of cardiovascular diseases and need for effective diagnostics
    • Rise of point-of-care testing for cardiac markers worldwide
    • Initiatives encouraging early detection and screening of cardiovascular diseases
  • Market Restraints
    • Adverse recalls of cardiac marker testing products
  • Market Opportunities
    • Advancements in testing technologies and integration of new biomarkers
    • Shift toward personalized medicine and introduction of tailored cardiac marker testing
  • Market Challenges
    • Concerns associated with inaccuracy and limited specificity of cardiac marker testing

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Marker Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Marker Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Marker Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Marker Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Marker Testing Market

A detailed market share analysis in the Cardiac Marker Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Marker Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Marker Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Marker Testing Market

A strategic analysis of the Cardiac Marker Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Marker Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Assure Tech (Hangzhou) Co., Ltd., Atlas Medical GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biomerieux SA, Boditech Med Inc., Charles River Laboratories International, Inc., Cleerly, Inc., Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche AG, HyTest Ltd., Laboratory Corporation of America Holdings, LightDeck Diagnostics, Merck KGaA, Natera, Inc., PerkinElmer Inc., Qiagen N.V., Quest Diagnostics, QuidelOrtho Corporation, Randox Laboratories Ltd., Sekbio, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Tosoh Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Marker Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments and Reagents & Kits. The Instruments is further studied across Chemiluminescence, ELISA, Immunochromatography, and Immunofluorescence.
  • Based on Biomarker, market is studied across BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP, Myoglobin, and Troponin.
  • Based on Type of Testing, market is studied across Laboratory Testing and Point-Of-Care Testing.
  • Based on Disease, market is studied across Congestive Heart Failure and Myocardial Infarction.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cardiovascular diseases and need for effective diagnostics
      • 5.1.1.2. Rise of point-of-care testing for cardiac markers worldwide
      • 5.1.1.3. Initiatives encouraging early detection and screening of cardiovascular diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse recalls of cardiac marker testing products
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in testing technologies and integration of new biomarkers
      • 5.1.3.2. Shift toward personalized medicine and introduction of tailored cardiac marker testing
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with inaccuracy and limited specificity of cardiac marker testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significance of diagnostic instruments in cardiac marker testing
    • 5.2.2. Biomarker: Rising utilization of Troponin biomarker for cardiac assessment
    • 5.2.3. Type of Testing: Increasing adoption of Point-of-Care testing
    • 5.2.4. Disease: Extensive applications of cardiac marker testing in myocardial infarction
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Marker Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
    • 6.2.1. Chemiluminescence
    • 6.2.2. ELISA
    • 6.2.3. Immunochromatography
    • 6.2.4. Immunofluorescence
  • 6.3. Reagents & Kits

7. Cardiac Marker Testing Market, by Biomarker

  • 7.1. Introduction
  • 7.2. BNP Or NT-ProBNP
  • 7.3. Ceratine Kinase-MB
  • 7.4. hs-CRP
  • 7.5. Myoglobin
  • 7.6. Troponin

8. Cardiac Marker Testing Market, by Type of Testing

  • 8.1. Introduction
  • 8.2. Laboratory Testing
  • 8.3. Point-Of-Care Testing

9. Cardiac Marker Testing Market, by Disease

  • 9.1. Introduction
  • 9.2. Congestive Heart Failure
  • 9.3. Myocardial Infarction

10. Americas Cardiac Marker Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cardiac Marker Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cardiac Marker Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Mindray Expands Cardiac Biomarker Portfolio with Launch of New Assays
    • 13.3.2. NOWDx and AeenaDx Announce Merger
    • 13.3.3. Pathkind Labs, Roche Diagnostics Partner to Release Cardiac Biomarker
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Assure Tech (Hangzhou) Co., Ltd.
  • 4. Atlas Medical GmbH
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Bio-Techne Corporation
  • 8. Biomerieux SA
  • 9. Boditech Med Inc.
  • 10. Charles River Laboratories International, Inc.
  • 11. Cleerly, Inc.
  • 12. Danaher Corporation
  • 13. DiaSorin S.p.A.
  • 14. Eurofins Scientific SE
  • 15. F. Hoffmann-La Roche AG
  • 16. HyTest Ltd.
  • 17. Laboratory Corporation of America Holdings
  • 18. LightDeck Diagnostics
  • 19. Merck KGaA
  • 20. Natera, Inc.
  • 21. PerkinElmer Inc.
  • 22. Qiagen N.V.
  • 23. Quest Diagnostics
  • 24. QuidelOrtho Corporation
  • 25. Randox Laboratories Ltd.
  • 26. Sekbio
  • 27. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 28. Siemens Healthineers AG
  • 29. Thermo Fisher Scientific Inc.
  • 30. Tosoh Corporation

LIST OF FIGURES

  • FIGURE 1. CARDIAC MARKER TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC MARKER TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CARDIAC MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CARDIAC MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC MARKER TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC MARKER TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BNP OR NT-PROBNP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CERATINE KINASE-MB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HS-CRP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 236. CARDIAC MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. CARDIAC MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023